Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 14, Number 11—November 2008

Research

Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus, Rural Southwestern Alaska1

Michael Z. DavidComments to Author , Karen M. Rudolph, Thomas W. Hennessy, Susan Boyle-Vavra, and Robert S. Daum
Author affiliations: University of Chicago, Chicago, Illinois, USA (M.Z. David, S. Boyle-Vavra, R.S. Daum); Centers for Disease Control and Prevention, Anchorage, Alaska, USA (K.M. Rudolph, T.W. Hennessy);

Main Article

Table 2

Demographic and clinical characteristics for 120 patients infected with MRSA isolates in the prospective collection, southwestern Alaska, 2004–2006*

Characteristic No. (%)
Sex
Male 61 (50.8)
Female 56 (46.7)
Unknown
3 (2.5)
Age, y
>1–2 11 (9.2)
3–12 14 (11.7)
13–20 22 (18.3)
21–49 53 (44.2)
>50 18 (15.0)
Unknown
2 (0.2)
Location of care
Inpatient 11 (9.2)
Outpatient 106 (88.4)
Emergency department 59 (49.2)
Other outpatient 47 (39.2)
Unknown
3 (2.5)
Place of onset by 72-h rule†
Community 114 (95.0)
Hospital 1 (0.8)
Unknown
5 (3.3)
Site of isolation
Blood 3 (2.5)
Respiratory tract 1 (0.8)
Skin/wound 108 (90.0)
Urine 2 (1.7)
Bone/joint 1 (0.8)
Other 5 (4.2)

*MRSA, methicillin-resistant Staphylococcus aureus.
†MRSA isolates were considered community onset if they were obtained from a patient in the outpatient setting or from a hospitalized patient within 72 h of admission; only 1 isolate was obtained from a patient who was considered to have had onset of the infection in the hospital.

Main Article

1Portions of this study were presented at the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, September 17–20, 2007, Chicago, IL, USA.

TOP